![Oil settles 1% lower as Mideast ceasefire talks ease supply disruption concerns](https://i-invdn-com.investing.com/news/external-images-thumbnails/LYNXMPEK64021_L.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1122 | 1049 | 1280 | 1309 | 1953 | 3537 |
Fund Return | 12.16% | 4.86% | 27.96% | 9.38% | 14.32% | 13.47% |
Place in category | 431 | 148 | 255 | 403 | 119 | 53 |
% in Category | 63 | 18 | 30 | 58 | 13 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife SI Idl US Div incm Fd 75PL | 605.73M | 8.68 | 6.52 | 11.73 | ||
Manulife SI Ideal US Div incm 100PL | 605.73M | 8.41 | 6.01 | 11.36 | ||
Manulife SI Ideal US Div incm Fd 75 | 605.73M | 8.39 | 5.86 | 11.07 | ||
Manulife S2 Ideal US Div incm 100PL | 605.73M | 8.44 | 5.93 | 11.12 | ||
Manulife S2 Idl US Div incm Fd 75PL | 605.73M | 8.65 | 6.34 | 11.45 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PH N US Multi Style All Cap Eq D | 9.07B | 16.16 | 13.74 | 13.43 | ||
PH N US Multi Style All Cap Eq F | 9.07B | 16.27 | 14.01 | 13.70 | ||
TD U.S. Blue Chip Equity Fund I CAD | 6.67B | 11.58 | 6.07 | 13.87 | ||
TD U.S. Blue Chip Equity Fund D CAD | 6.67B | 12.07 | 7.05 | - | ||
RBC Priv US Lg Cap Cr Eq Sr F CAD | 5.4B | 16.88 | 14.48 | 14.31 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Manulife US All Cap Equity T6 | - | 101.31 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review